Literature DB >> 15078971

Transduction of terminally differentiated neurons by avian sarcoma virus.

James G Greger1, Richard A Katz, Konstantin Taganov, Glenn F Rall, Anna Marie Skalka.   

Abstract

Recent studies have demonstrated that avian sarcoma virus (ASV) can transduce cycle-arrested cells. Here, we have assessed quantitatively the transduction efficiency of an ASV vector in naturally arrested mouse hippocampal neurons. This efficiency was determined by comparing the number of transduced cells after infection of differentiated neurons versus dividing progenitor cells. The results indicate that ASV is able to transduce these differentiated neurons efficiently and that this activity is not the result of infection of residual dividing cells. The transduction efficiency of the ASV vector was found to be intermediate between the relatively high and low efficiencies obtained with human immunodeficiency virus type 1 and murine leukemia virus vectors, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078971      PMCID: PMC387698          DOI: 10.1128/jvi.78.9.4902-4906.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1.

Authors:  V N Kim; K Mitrophanous; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

2.  Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response.

Authors:  René Daniel; Gary Kao; Konstantin Taganov; James G Greger; Olga Favorova; George Merkel; Tim J Yen; Richard A Katz; Anna Marie Skalka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

3.  Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases.

Authors:  G Kukolj; K S Jones; A M Skalka
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.

Authors:  E V Barsov; S H Hughes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: kinetics of the arrest and expression of the cell cycle marker proliferating cell nuclear antigen in Raji cells.

Authors:  K Takase; M Sawai; K Yamamoto; J Yata; Y Takasaki; H Teraoka; K Tsukada
Journal:  Cell Growth Differ       Date:  1992-08

6.  Characterization of the nuclear localization signal in the avian sarcoma virus integrase.

Authors:  G Kukolj; R A Katz; A M Skalka
Journal:  Gene       Date:  1998-11-26       Impact factor: 3.688

7.  Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus.

Authors:  P F Lewis; M Emerman
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

9.  Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes.

Authors:  J B Weinberg; T J Matthews; B R Cullen; M H Malim
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Integration of murine leukemia virus DNA depends on mitosis.

Authors:  T Roe; T C Reynolds; G Yu; P O Brown
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  10 in total

1.  High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells.

Authors:  Julie H Yu; David V Schaffer
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Transduction of nondividing human macrophages with gammaretrovirus-derived vectors.

Authors:  Loraine Jarrosson-Wuilleme; Caroline Goujon; Jeanine Bernaud; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 3.  Avian retroviral replication.

Authors:  James Justice; Karen L Beemon
Journal:  Curr Opin Virol       Date:  2013-09-04       Impact factor: 7.090

4.  The avian retroviral receptor Tva mediates the uptake of transcobalamin bound vitamin B12 (cobalamin).

Authors:  Veronika Krchlíková; Jana Mikešová; Josef Geryk; Cyril Bařinka; Ebba Nexo; Sergey N Fedosov; Jan Kosla; Dana Kučerová; Markéta Reinišová; Jiří Hejnar; Daniel Elleder
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

5.  Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.

Authors:  Kerstin B Kaufmann; Christian Brendel; Julia D Suerth; Uta Mueller-Kuller; Linping Chen-Wichmann; Joachim Schwäble; Shweta Pahujani; Hana Kunkel; Axel Schambach; Christopher Baum; Manuel Grez
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

6.  The core element of a CpG island protects avian sarcoma and leukosis virus-derived vectors from transcriptional silencing.

Authors:  Filip Senigl; Jirí Plachý; Jirí Hejnar
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

Review 7.  The inside out of lentiviral vectors.

Authors:  Stéphanie Durand; Andrea Cimarelli
Journal:  Viruses       Date:  2011-02-14       Impact factor: 5.818

8.  HIV infection of non-dividing cells: a divisive problem.

Authors:  Ariberto Fassati
Journal:  Retrovirology       Date:  2006-10-26       Impact factor: 4.602

9.  New α- and SIN γ-retrovectors for safe transduction and specific transgene expression in pancreatic β cell lines.

Authors:  Olivier Albagli; Alicia Maugein; Lukas Huijbregts; Delphine Bredel; Géraldine Carlier; Patrick Martin; Raphaël Scharfmann
Journal:  BMC Biotechnol       Date:  2019-06-17       Impact factor: 2.563

10.  Nuclear import of Avian Sarcoma Virus integrase is facilitated by host cell factors.

Authors:  Mark D Andrake; Monica M Sauter; Kim Boland; Andrew D Goldstein; Maryem Hussein; Anna Marie Skalka
Journal:  Retrovirology       Date:  2008-08-07       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.